Cystadenocarcinoma

A combination of immunohistochemical markers, MUC1, MUC5AC, PAX8 and growth pattern for characterization of mucinous neoplasm of the ovary
Anca Chelariu-Raicu, Eva Holley, Doris Mayr, Frederick Klauschen, Fabienne Wehweck, Miriam Rottmann, Mirjana Kessler, Till Kaltofen, Bastian Czogalla, Fabian Trillsch, Sven Mahner, Elisa Schmoeckel

International Journal of Gynecologic Cancer May 2022, 32 (5) 662-668; DOI: 10.1136/ijgc-2021-003104
There is no role for hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer
Richard Schwameis, Luis Chiva, Philipp Harter

International Journal of Gynecologic Cancer Apr 2022, 32 (4) 578; DOI: 10.1136/ijgc-2022-003348
Outcomes of comprehensive lymphadenectomy for patients with advanced stage ovarian carcinoma and rare histologic sub-types
Dimitrios Nasioudis, Nawar A Latif, Ashley F Haggerty, Robert L Giuntoli II, Sarah H Kim, Emily M Ko

International Journal of Gynecologic Cancer Aug 2021, 31 (8) 1132-1136; DOI: 10.1136/ijgc-2021-002559
Frequency and prediction of deep uterine involvement in advanced high-grade epithelial ovarian cancer: is uterine preservation an option?
Tamar Perri, Gal Harel, Tal Dadon, Aya Mor-Sasson, Itai Yagel, Gilad Ben-Baruch, Jacob Korach

International Journal of Gynecologic Cancer Feb 2021, 31 (2) 251-256; DOI: 10.1136/ijgc-2020-001850
Management of low-grade serous ovarian neoplasm in the setting of fertility preservation
Zibi Marchocki, Marjan Rouzbahman, Tanya Chawla, Taymaa May

International Journal of Gynecologic Cancer Nov 2020, 30 (11) 1834-1839; DOI: 10.1136/ijgc-2020-001838
Pre-operative serum CA125, peritoneal cancer index and intra-operative mapping score as predictors of surgical results in primary epithelial ovarian cancer
Mustafa Zelal Muallem, Jalid Sehouli, Rolf Richter, Aygun Babayeva, Khayal Gasimli, Asya Parashkevova

International Journal of Gynecologic Cancer Jan 2020, 30 (1) 62-66; DOI: 10.1136/ijgc-2019-000778
Incidence of germline BRCA1/2 mutations in women with tubo-ovarian high-grade serous carcinomas with and without serous tubal intra-epithelial carcinomas
Cassandra B Dowson, Colin Stewart, Sarah O'Sullivan, Nicholas Pachter, Lyn Schofield, Paul A Cohen

International Journal of Gynecologic Cancer Jan 2020, 30 (1) 94-99; DOI: 10.1136/ijgc-2019-000540
Prognostic significance of PD-1 and PD-L1 positive tumor-infiltrating immune cells in ovarian carcinoma
Paul Buderath, Fabian Mairinger, Elena Mairinger, Katharina Böhm, Pawel Mach, Kurt Werner Schmid, Rainer Kimmig, Sabine Kasimir-Bauer, Agnes Bankfalvi, Daniela Westerwick, Thomas Hager

International Journal of Gynecologic Cancer Nov 2019, 29 (9) 1389-1395; DOI: 10.1136/ijgc-2019-000609
BRCA1, Ki67, and β-Catenin Immunoexpression Is Not Related to Differentiation, Platinum Response, or Prognosis in Women With Low- and High-Grade Serous Ovarian Carcinoma
Luis Felipe Sallum, Liliana Andrade, Larissa Bastos Eloy da Costa, Susana Ramalho, Amanda Canato Ferracini, Rodrigo de Andrade Natal, Angelo Borsarelli Carvalho Brito, Luis Otávio Sarian, Sophie Derchain

International Journal of Gynecologic Cancer Mar 2018, 28 (3) 437-447; DOI: 10.1097/IGC.0000000000001205
Uterine Papillary Serous Carcinoma: A Single-Institution Review of 62 Cases
Carin Black, Amy Feng, Sophie Bittinger, Michael Quinn, Deborah Neesham, Orla McNally

International Journal of Gynecologic Cancer Jan 2016, 26 (1) 133-140; DOI: 10.1097/IGC.0000000000000569

Main menu

Cystadenocarcinoma

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Cystadenocarcinoma

Pages